Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation

Details for Australian Patent Application No. 2006253842 (hide)

Owner Glenmark Pharmaceuticals S.A.

Inventors Muthuppalaniappan, Meyyappan; Narayanan, Shridhar; Joshi, Neelima Khairatkar; Gullapalli, Srinivas; Balasubramanian, Gopalan

Agent Davies Collison Cave

Pub. Number AU-A-2006253842

PCT Pub. Number WO2006/129178

Priority 60/744,071 31.03.06 US; 60/696,433 01.07.05 US; 1370/MUM/2005 31.10.05 IN; 689/MUM/2006 03.05.06 IN; 659/MUM/2005 02.06.05 IN; 344/MUM/2006 09.03.06 IN

Filing date 1 June 2006

Wipo publication date 7 December 2006

International Classifications

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

C07D 231/54 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/129178 Priority application(s): WO2006/129178

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006253844-Systems and methods to reduce the pressure in a pressure chamber

2006253805-Novel piperidine carboxylic acid amide derivatives